(Q33844807)

29 July 2017

1 reference

title

NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials (English)

1 reference

29 July 2017

0 references

Sang CN

1

1 reference

29 July 2017

publication date

1 January 2000

1 reference

Journal of Pain and Symptom Management

29 July 2017

published in

1 reference

29 July 2017

volume

19

1 reference

29 July 2017

issue

1 Suppl

1 reference

29 July 2017

page(s)

S21-5

1 reference

Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900125-6

7 January 2021

Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900125-6

7 January 2021

Effect of racemic mixture and the (S+)-isomer of ketamine on temporal and spatial summation of pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900125-6

7 January 2021

Effects of dextromethorphan in clinical doses on capsaicin-induced ongoing pain and mechanical hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900125-6

7 January 2021

Comparison of ketamine and pethidine in experimental and postoperative pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900125-6

7 January 2021

Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900125-6

7 January 2021

Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900125-6

7 January 2021

Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900125-6

7 January 2021

NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900125-6

7 January 2021

The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900125-6

7 January 2021

High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900125-6

7 January 2021

Sensitization of cat dorsal horn neurons to innocuous mechanical stimulation after intradermal injection of capsaicin

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900125-6

7 January 2021

Neurogenic hyperalgesia: the search for the primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900125-6

7 January 2021

Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900125-6

7 January 2021

Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 design

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900125-6

7 January 2021

Scopolamine butylbromide plus octreotide in unresponsive bowel obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900125-6

7 January 2021

10.1016/S0885-3924(99)00125-6

Identifiers

DOI

1 reference

29 July 2017

1 reference